Shenzhen Bioeasy Biotechnology Co., Ltd. Stock: price and insider trades · China
易瑞生物
Shenzhen Bioeasy Biotechnology Co., Ltd.: what insiders have been doing
Shenzhen Bioeasy Biotechnology Co., Ltd. belongs to the Health Care sector. Filings by its managers are published through SSE / SZSE (CSRC). Nothing new has been filed by managers of Shenzhen Bioeasy Biotechnology Co., Ltd. in twelve months, the latest record being from 23 March 2023.
Since 2022, the database holds no purchases and 3 sales by insiders of the company.
In the same sector, recent insider purchases at Dynavox Group AB and Vetoquinol SA also feature in our signals. This summary is built from SSE / SZSE (CSRC) disclosures alone and does not predict where the share price will go.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
About Shenzhen Bioeasy Biotechnology Co., Ltd.
易瑞生物 is a company focused on the healthcare and pharmaceutical sector, specializing in the development of biopharmaceutical solutions. It is listed on the XSHE market.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
